微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 4.42% | 2.08% | -66.34% | 12/69 | 2.26% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 13.13% | -38.82% | -5.74% | 11/69 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 13.93% | -30.63% | 52.24% | 8/69 | 3.08% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 9.15% | -21.93% | 111.32% | 10/69 | 0.67% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 4.33% | -16.89% | -79.82% | 13/69 | 1.53% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 21.46% | -7.54% | 6.87% | 5/69 | 0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 20.08% | 9.61% | 71.33% | 2/69 | 7.26% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 11.72% | 21.2% | 124.95% | 6/69 | 4.93% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 5.21% | -5.79% | -77.55% | 15/69 | 3.21% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 23.21% | 8.66% | 26.69% | 3/69 | 6.65% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 18.32% | 1.89% | 89.45% | 3/69 | 5.16% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 9.67% | -15.99% | 74.86% | 5/69 | 3.2% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 5.53% | 5.13% | -74.11% | 6/69 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 21.36% | 95.78% | 18.8% | 2/69 | 4.54% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 17.98% | 79.62% | 56.21% | 3/69 | 7.54% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 11.51% | 170.19% | 118.82% | 3/69 | 4.68% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 5.26% | 237.18% | -51.79% | 8/69 | 2.7% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 10.91% | 55.86% | 8.99% | 19/69 | 0.1% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 10.01% | 57.64% | 134.98% | 19/69 | 6.79% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 4.26% | -0.93% | 173.08% | 29/69 | 3.75% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 1.56% | -33.62% | -77.71% | 42/69 | 2.14% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | 7% | 25.45% | 10.24% | 38/69 | 5.86% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 6.35% | -3.2% | 47.67% | 39/69 | 7.3% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 4.3% | -6.32% | 82.98% | 36/69 | 4.72% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 2.35% | -10.31% | -57.89% | 38/69 | 2.92% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 5.58% | -19.83% | -14.94% | 47/69 | 7.87% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 6.56% | -5.61% | 42.92% | 42/69 | 8.02% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 4.59% | 5.28% | 75.19% | 35/69 | 5.03% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 2.62% | 51.45% | -62.36% | 33/69 | 2.75% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 6.96% | 43.51% | 0.14% | 47/69 | 9.93% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 6.95% | 22.79% | 59.4% | 41/69 | 8.39% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 4.36% | 6.08% | 152.02% | 40/69 | 5.24% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 1.73% | -25.75% | -64.33% | 41/69 | 2.62% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 4.85% | -22.65% | -14.31% | 53/69 | 10.02% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 5.66% | -24.33% | 37.71% | 39/69 | 9.32% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 4.11% | 1.99% | 76.39% | 42/69 | 5.04% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 2.33% | -10.04% | -62.84% | 35/69 | 4.1% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 6.27% | -41.57% | -16.18% | 48/69 | 11.34% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 7.48% | -31.69% | 85.61% | 33/69 | 8.44% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 4.03% | -33.61% | 55.6% | 40/69 | 5.48% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 2.59% | -13.09% | -75.86% | 32/69 | 2.9% | 济川药业 | 21.37% | 行业排名> |